Determination of genetic predisposition to early breast cancer in women of Kazakh ethnicity

Gulnur Zhunussova; Nazgul Omarbayeva; Dilyara Kaidarova; Saltanat Abdikerim; Natalya Mit; Ilya Kisselev; Kanagat Yergali; Aigul Zhunussova; Tatyana Goncharova; Aliya Abdrakhmanova; Leyla Djansugurova

doi:10.18632/oncotarget.28518

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Determination of genetic predisposition to early breast cancer in women of Kazakh ethnicity

Gulnur Zhunussova _, Nazgul Omarbayeva _, Dilyara Kaidarova, Saltanat Abdikerim, Natalya Mit, Ilya Kisselev, Kanagat Yergali, Aigul Zhunussova, Tatyana Goncharova, Aliya Abdrakhmanova and Leyla Djansugurova

PDF | Full Text | Supplementary Files | How to cite | Press Release

Oncotarget. 2023; 14:860-877. https://doi.org/10.18632/oncotarget.28518

Metrics: PDF 573 views | Full Text 2796 views | ?

Abstract

Gulnur Zhunussova1^,3, Nazgul Omarbayeva2^,4, Dilyara Kaidarova2^,4, Saltanat Abdikerim1^,3, Natalya Mit1, Ilya Kisselev1, Kanagat Yergali1, Aigul Zhunussova1, Tatyana Goncharova2, Aliya Abdrakhmanova2^,4 and Leyla Djansugurova1^,3

1 Laboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan

2 Kazakh Institute of Oncology and Radiology, Almaty 050060, Kazakhstan

3 Al-Farabi Kazakh National University, Almaty 050060, Kazakhstan

4 Asfendiyarov Kazakh National Medical University, Almaty 050060, Kazakhstan

Correspondence to:

Gulnur Zhunussova,	email:	[email protected]
Nazgul Omarbayeva,	email:	[email protected]

Keywords: early-onset breast cancer; triple negative breast cancer; next-generation sequencing; pathogenic variant; Kazakh population

Received: May 06, 2023 Accepted: September 21, 2023 Published: October 04, 2023

Copyright: © 2023 Zhunussova et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

ABSTRACT

Breast cancer (BC) is the most common type of cancer among women in Kazakhstan. To date, little data are available on the spectrum of genetic variation in Kazakh women with BC. We aimed to identify population-specific genetic markers associated with the risk of developing early-onset BC and test their association with clinical and prognostic factors. The study included 224 Kazakh women diagnosed with BC (≤40 age). Entire coding regions (>1700 exons) and the flanking noncoding regions of 94 cancer-associated genes were sequenced from blood DNA using MiSeq platform. We identified 38 unique pathogenic variants (PVs) in 13 different cancer-predisposing genes among 57 patients (25.4%), of which 6 variants were novel. In total, 12 of the 38 distinct PVs were detected recurrently, including BRCA1 c.5266dup, c.5278-2del, and c.2T>C, and BRCA2 c.9409dup and c.9253del that may be founder in this population. BRCA1 carriers were significantly more likely to develop triple-negative BC (OR = 6.61, 95% CI 2.44–17.91, p = 0.0002) and have family history of BC (OR = 3.17, 95% CI 1.14–8.76, p = 0.03) compared to non-carriers. This study allowed the identification of PVs specific to early-onset BC, which may be used as a foundation to develop regional expertise and diagnostic tools for early detection of BC in young Kazakh women.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28518

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

Determination of genetic predisposition to early breast cancer in women of Kazakh ethnicity

Abstract